Global Oral Cholera Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Oral Cholera Vaccine market size was valued at USD 87 million in 2023 and is forecast to a readjusted size of USD 141.7 million by 2030 with a CAGR of 7.1% during review period.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
The Global Info Research report includes an overview of the development of the Oral Cholera Vaccine industry chain, the market status of Preventive Campaigns (Euvichol-Plus, DUKORAL), Outbreak Response (Euvichol-Plus, DUKORAL), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Cholera Vaccine.
Regionally, the report analyzes the Oral Cholera Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Cholera Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Cholera Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Cholera Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Euvichol-Plus, DUKORAL).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Cholera Vaccine market.
Regional Analysis: The report involves examining the Oral Cholera Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Cholera Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Cholera Vaccine:
Company Analysis: Report covers individual Oral Cholera Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Cholera Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Preventive Campaigns, Outbreak Response).
Technology Analysis: Report covers specific technologies relevant to Oral Cholera Vaccine. It assesses the current state, advancements, and potential future developments in Oral Cholera Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Cholera Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral Cholera Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Oral Cholera Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Cholera Vaccine, with price, sales, revenue and global market share of Oral Cholera Vaccine from 2019 to 2024.
Chapter 3, the Oral Cholera Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Cholera Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Cholera Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Cholera Vaccine.
Chapter 14 and 15, to describe Oral Cholera Vaccine sales channel, distributors, customers, research findings and conclusion.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
The Global Info Research report includes an overview of the development of the Oral Cholera Vaccine industry chain, the market status of Preventive Campaigns (Euvichol-Plus, DUKORAL), Outbreak Response (Euvichol-Plus, DUKORAL), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Cholera Vaccine.
Regionally, the report analyzes the Oral Cholera Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Cholera Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Cholera Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Cholera Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Euvichol-Plus, DUKORAL).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Cholera Vaccine market.
Regional Analysis: The report involves examining the Oral Cholera Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Cholera Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Cholera Vaccine:
Company Analysis: Report covers individual Oral Cholera Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Cholera Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Preventive Campaigns, Outbreak Response).
Technology Analysis: Report covers specific technologies relevant to Oral Cholera Vaccine. It assesses the current state, advancements, and potential future developments in Oral Cholera Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Cholera Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral Cholera Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Euvichol-Plus
- DUKORAL
- Shanchol
- Others
- Preventive Campaigns
- Outbreak Response
- PaxVax
- Sanofi
- Valneva
- EuBiologics
- United Biotech
- Vabiotech
- PaxVax
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Oral Cholera Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Cholera Vaccine, with price, sales, revenue and global market share of Oral Cholera Vaccine from 2019 to 2024.
Chapter 3, the Oral Cholera Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Cholera Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Cholera Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Cholera Vaccine.
Chapter 14 and 15, to describe Oral Cholera Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oral Cholera Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Cholera Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Euvichol-Plus
1.3.3 DUKORAL
1.3.4 Shanchol
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Cholera Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Preventive Campaigns
1.4.3 Outbreak Response
1.5 Global Oral Cholera Vaccine Market Size & Forecast
1.5.1 Global Oral Cholera Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oral Cholera Vaccine Sales Quantity (2019-2030)
1.5.3 Global Oral Cholera Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Oral Cholera Vaccine Product and Services
2.1.4 PaxVax Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 PaxVax Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Oral Cholera Vaccine Product and Services
2.2.4 Sanofi Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Oral Cholera Vaccine Product and Services
2.3.4 Valneva Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva Recent Developments/Updates
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Oral Cholera Vaccine Product and Services
2.4.4 EuBiologics Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EuBiologics Recent Developments/Updates
2.5 United Biotech
2.5.1 United Biotech Details
2.5.2 United Biotech Major Business
2.5.3 United Biotech Oral Cholera Vaccine Product and Services
2.5.4 United Biotech Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 United Biotech Recent Developments/Updates
2.6 Vabiotech
2.6.1 Vabiotech Details
2.6.2 Vabiotech Major Business
2.6.3 Vabiotech Oral Cholera Vaccine Product and Services
2.6.4 Vabiotech Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Vabiotech Recent Developments/Updates
2.7 PaxVax
2.7.1 PaxVax Details
2.7.2 PaxVax Major Business
2.7.3 PaxVax Oral Cholera Vaccine Product and Services
2.7.4 PaxVax Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 PaxVax Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ORAL CHOLERA VACCINE BY MANUFACTURER
3.1 Global Oral Cholera Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oral Cholera Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Oral Cholera Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Oral Cholera Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Oral Cholera Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Oral Cholera Vaccine Manufacturer Market Share in 2023
3.5 Oral Cholera Vaccine Market: Overall Company Footprint Analysis
3.5.1 Oral Cholera Vaccine Market: Region Footprint
3.5.2 Oral Cholera Vaccine Market: Company Product Type Footprint
3.5.3 Oral Cholera Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oral Cholera Vaccine Market Size by Region
4.1.1 Global Oral Cholera Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Oral Cholera Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Oral Cholera Vaccine Average Price by Region (2019-2030)
4.2 North America Oral Cholera Vaccine Consumption Value (2019-2030)
4.3 Europe Oral Cholera Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Oral Cholera Vaccine Consumption Value (2019-2030)
4.5 South America Oral Cholera Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Oral Cholera Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Oral Cholera Vaccine Consumption Value by Type (2019-2030)
5.3 Global Oral Cholera Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Oral Cholera Vaccine Consumption Value by Application (2019-2030)
6.3 Global Oral Cholera Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Oral Cholera Vaccine Market Size by Country
7.3.1 North America Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Oral Cholera Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Oral Cholera Vaccine Market Size by Country
8.3.1 Europe Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Oral Cholera Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oral Cholera Vaccine Market Size by Region
9.3.1 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oral Cholera Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Oral Cholera Vaccine Market Size by Country
10.3.1 South America Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Oral Cholera Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oral Cholera Vaccine Market Size by Country
11.3.1 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oral Cholera Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Oral Cholera Vaccine Market Drivers
12.2 Oral Cholera Vaccine Market Restraints
12.3 Oral Cholera Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oral Cholera Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Cholera Vaccine
13.3 Oral Cholera Vaccine Production Process
13.4 Oral Cholera Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Cholera Vaccine Typical Distributors
14.3 Oral Cholera Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Oral Cholera Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Cholera Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Euvichol-Plus
1.3.3 DUKORAL
1.3.4 Shanchol
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Cholera Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Preventive Campaigns
1.4.3 Outbreak Response
1.5 Global Oral Cholera Vaccine Market Size & Forecast
1.5.1 Global Oral Cholera Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oral Cholera Vaccine Sales Quantity (2019-2030)
1.5.3 Global Oral Cholera Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Oral Cholera Vaccine Product and Services
2.1.4 PaxVax Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 PaxVax Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Oral Cholera Vaccine Product and Services
2.2.4 Sanofi Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Oral Cholera Vaccine Product and Services
2.3.4 Valneva Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva Recent Developments/Updates
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Oral Cholera Vaccine Product and Services
2.4.4 EuBiologics Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EuBiologics Recent Developments/Updates
2.5 United Biotech
2.5.1 United Biotech Details
2.5.2 United Biotech Major Business
2.5.3 United Biotech Oral Cholera Vaccine Product and Services
2.5.4 United Biotech Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 United Biotech Recent Developments/Updates
2.6 Vabiotech
2.6.1 Vabiotech Details
2.6.2 Vabiotech Major Business
2.6.3 Vabiotech Oral Cholera Vaccine Product and Services
2.6.4 Vabiotech Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Vabiotech Recent Developments/Updates
2.7 PaxVax
2.7.1 PaxVax Details
2.7.2 PaxVax Major Business
2.7.3 PaxVax Oral Cholera Vaccine Product and Services
2.7.4 PaxVax Oral Cholera Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 PaxVax Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ORAL CHOLERA VACCINE BY MANUFACTURER
3.1 Global Oral Cholera Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oral Cholera Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Oral Cholera Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Oral Cholera Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Oral Cholera Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Oral Cholera Vaccine Manufacturer Market Share in 2023
3.5 Oral Cholera Vaccine Market: Overall Company Footprint Analysis
3.5.1 Oral Cholera Vaccine Market: Region Footprint
3.5.2 Oral Cholera Vaccine Market: Company Product Type Footprint
3.5.3 Oral Cholera Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oral Cholera Vaccine Market Size by Region
4.1.1 Global Oral Cholera Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Oral Cholera Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Oral Cholera Vaccine Average Price by Region (2019-2030)
4.2 North America Oral Cholera Vaccine Consumption Value (2019-2030)
4.3 Europe Oral Cholera Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Oral Cholera Vaccine Consumption Value (2019-2030)
4.5 South America Oral Cholera Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Oral Cholera Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Oral Cholera Vaccine Consumption Value by Type (2019-2030)
5.3 Global Oral Cholera Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Oral Cholera Vaccine Consumption Value by Application (2019-2030)
6.3 Global Oral Cholera Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Oral Cholera Vaccine Market Size by Country
7.3.1 North America Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Oral Cholera Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Oral Cholera Vaccine Market Size by Country
8.3.1 Europe Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Oral Cholera Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oral Cholera Vaccine Market Size by Region
9.3.1 Asia-Pacific Oral Cholera Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oral Cholera Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Oral Cholera Vaccine Market Size by Country
10.3.1 South America Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Oral Cholera Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oral Cholera Vaccine Market Size by Country
11.3.1 Middle East & Africa Oral Cholera Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oral Cholera Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Oral Cholera Vaccine Market Drivers
12.2 Oral Cholera Vaccine Market Restraints
12.3 Oral Cholera Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oral Cholera Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Cholera Vaccine
13.3 Oral Cholera Vaccine Production Process
13.4 Oral Cholera Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Cholera Vaccine Typical Distributors
14.3 Oral Cholera Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Oral Cholera Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oral Cholera Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Oral Cholera Vaccine Product and Services
Table 6. PaxVax Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. PaxVax Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Oral Cholera Vaccine Product and Services
Table 11. Sanofi Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Valneva Basic Information, Manufacturing Base and Competitors
Table 14. Valneva Major Business
Table 15. Valneva Oral Cholera Vaccine Product and Services
Table 16. Valneva Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Valneva Recent Developments/Updates
Table 18. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 19. EuBiologics Major Business
Table 20. EuBiologics Oral Cholera Vaccine Product and Services
Table 21. EuBiologics Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EuBiologics Recent Developments/Updates
Table 23. United Biotech Basic Information, Manufacturing Base and Competitors
Table 24. United Biotech Major Business
Table 25. United Biotech Oral Cholera Vaccine Product and Services
Table 26. United Biotech Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. United Biotech Recent Developments/Updates
Table 28. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 29. Vabiotech Major Business
Table 30. Vabiotech Oral Cholera Vaccine Product and Services
Table 31. Vabiotech Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Vabiotech Recent Developments/Updates
Table 33. PaxVax Basic Information, Manufacturing Base and Competitors
Table 34. PaxVax Major Business
Table 35. PaxVax Oral Cholera Vaccine Product and Services
Table 36. PaxVax Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. PaxVax Recent Developments/Updates
Table 38. Global Oral Cholera Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 39. Global Oral Cholera Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Oral Cholera Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 41. Market Position of Manufacturers in Oral Cholera Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Oral Cholera Vaccine Production Site of Key Manufacturer
Table 43. Oral Cholera Vaccine Market: Company Product Type Footprint
Table 44. Oral Cholera Vaccine Market: Company Product Application Footprint
Table 45. Oral Cholera Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Oral Cholera Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Oral Cholera Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 48. Global Oral Cholera Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 49. Global Oral Cholera Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Oral Cholera Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Oral Cholera Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 52. Global Oral Cholera Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 53. Global Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Global Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Global Oral Cholera Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Oral Cholera Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Oral Cholera Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 58. Global Oral Cholera Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 59. Global Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 60. Global Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 61. Global Oral Cholera Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Oral Cholera Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Oral Cholera Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 64. Global Oral Cholera Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 65. North America Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 66. North America Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 67. North America Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 68. North America Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 69. North America Oral Cholera Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 70. North America Oral Cholera Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 71. North America Oral Cholera Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Oral Cholera Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Europe Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Europe Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Europe Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Europe Oral Cholera Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe Oral Cholera Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 79. Europe Oral Cholera Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Oral Cholera Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 82. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 83. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 84. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 85. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 86. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 87. Asia-Pacific Oral Cholera Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Oral Cholera Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 90. South America Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 91. South America Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 92. South America Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 93. South America Oral Cholera Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 94. South America Oral Cholera Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 95. South America Oral Cholera Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Oral Cholera Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East & Africa Oral Cholera Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Oral Cholera Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Oral Cholera Vaccine Raw Material
Table 106. Key Manufacturers of Oral Cholera Vaccine Raw Materials
Table 107. Oral Cholera Vaccine Typical Distributors
Table 108. Oral Cholera Vaccine Typical Customers
Table 1. Global Oral Cholera Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oral Cholera Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Oral Cholera Vaccine Product and Services
Table 6. PaxVax Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. PaxVax Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Oral Cholera Vaccine Product and Services
Table 11. Sanofi Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Valneva Basic Information, Manufacturing Base and Competitors
Table 14. Valneva Major Business
Table 15. Valneva Oral Cholera Vaccine Product and Services
Table 16. Valneva Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Valneva Recent Developments/Updates
Table 18. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 19. EuBiologics Major Business
Table 20. EuBiologics Oral Cholera Vaccine Product and Services
Table 21. EuBiologics Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EuBiologics Recent Developments/Updates
Table 23. United Biotech Basic Information, Manufacturing Base and Competitors
Table 24. United Biotech Major Business
Table 25. United Biotech Oral Cholera Vaccine Product and Services
Table 26. United Biotech Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. United Biotech Recent Developments/Updates
Table 28. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 29. Vabiotech Major Business
Table 30. Vabiotech Oral Cholera Vaccine Product and Services
Table 31. Vabiotech Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Vabiotech Recent Developments/Updates
Table 33. PaxVax Basic Information, Manufacturing Base and Competitors
Table 34. PaxVax Major Business
Table 35. PaxVax Oral Cholera Vaccine Product and Services
Table 36. PaxVax Oral Cholera Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. PaxVax Recent Developments/Updates
Table 38. Global Oral Cholera Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 39. Global Oral Cholera Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Oral Cholera Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 41. Market Position of Manufacturers in Oral Cholera Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Oral Cholera Vaccine Production Site of Key Manufacturer
Table 43. Oral Cholera Vaccine Market: Company Product Type Footprint
Table 44. Oral Cholera Vaccine Market: Company Product Application Footprint
Table 45. Oral Cholera Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Oral Cholera Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Oral Cholera Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 48. Global Oral Cholera Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 49. Global Oral Cholera Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Oral Cholera Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Oral Cholera Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 52. Global Oral Cholera Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 53. Global Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Global Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Global Oral Cholera Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Oral Cholera Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Oral Cholera Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 58. Global Oral Cholera Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 59. Global Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 60. Global Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 61. Global Oral Cholera Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Oral Cholera Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Oral Cholera Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 64. Global Oral Cholera Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 65. North America Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 66. North America Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 67. North America Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 68. North America Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 69. North America Oral Cholera Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 70. North America Oral Cholera Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 71. North America Oral Cholera Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Oral Cholera Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Europe Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Europe Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Europe Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Europe Oral Cholera Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe Oral Cholera Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 79. Europe Oral Cholera Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Oral Cholera Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 82. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 83. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 84. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 85. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 86. Asia-Pacific Oral Cholera Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 87. Asia-Pacific Oral Cholera Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Oral Cholera Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 90. South America Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 91. South America Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 92. South America Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 93. South America Oral Cholera Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 94. South America Oral Cholera Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 95. South America Oral Cholera Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Oral Cholera Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Middle East & Africa Oral Cholera Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East & Africa Oral Cholera Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Oral Cholera Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Oral Cholera Vaccine Raw Material
Table 106. Key Manufacturers of Oral Cholera Vaccine Raw Materials
Table 107. Oral Cholera Vaccine Typical Distributors
Table 108. Oral Cholera Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Oral Cholera Vaccine Picture
Figure 2. Global Oral Cholera Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oral Cholera Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Euvichol-Plus Examples
Figure 5. DUKORAL Examples
Figure 6. Shanchol Examples
Figure 7. Others Examples
Figure 8. Global Oral Cholera Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Oral Cholera Vaccine Consumption Value Market Share by Application in 2023
Figure 10. Preventive Campaigns Examples
Figure 11. Outbreak Response Examples
Figure 12. Global Oral Cholera Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Oral Cholera Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Oral Cholera Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Oral Cholera Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Oral Cholera Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Oral Cholera Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Oral Cholera Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Oral Cholera Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Oral Cholera Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Oral Cholera Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Oral Cholera Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Oral Cholera Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Oral Cholera Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Oral Cholera Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Oral Cholera Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Oral Cholera Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Oral Cholera Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Oral Cholera Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Oral Cholera Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Oral Cholera Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Oral Cholera Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Oral Cholera Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Oral Cholera Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Oral Cholera Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Oral Cholera Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Oral Cholera Vaccine Market Drivers
Figure 75. Oral Cholera Vaccine Market Restraints
Figure 76. Oral Cholera Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Oral Cholera Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Oral Cholera Vaccine
Figure 80. Oral Cholera Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Oral Cholera Vaccine Picture
Figure 2. Global Oral Cholera Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oral Cholera Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Euvichol-Plus Examples
Figure 5. DUKORAL Examples
Figure 6. Shanchol Examples
Figure 7. Others Examples
Figure 8. Global Oral Cholera Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Oral Cholera Vaccine Consumption Value Market Share by Application in 2023
Figure 10. Preventive Campaigns Examples
Figure 11. Outbreak Response Examples
Figure 12. Global Oral Cholera Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Oral Cholera Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Oral Cholera Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Oral Cholera Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Oral Cholera Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Oral Cholera Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Oral Cholera Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Oral Cholera Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Oral Cholera Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Oral Cholera Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Oral Cholera Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Oral Cholera Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Oral Cholera Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Oral Cholera Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Oral Cholera Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Oral Cholera Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Oral Cholera Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Oral Cholera Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Oral Cholera Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Oral Cholera Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Oral Cholera Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Oral Cholera Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Oral Cholera Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Oral Cholera Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Oral Cholera Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Oral Cholera Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Oral Cholera Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Oral Cholera Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Oral Cholera Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Oral Cholera Vaccine Market Drivers
Figure 75. Oral Cholera Vaccine Market Restraints
Figure 76. Oral Cholera Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Oral Cholera Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Oral Cholera Vaccine
Figure 80. Oral Cholera Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
